Literature DB >> 21443914

Hepatitis E virus infection in developed countries.

Tatsuo Miyamura1.   

Abstract

Hepatitis E was considered to be endemic infectious disease in developing countries in tropical or subtropical regions with poor sanitary conditions. Large, previously reported outbreaks were mainly due to contaminated water or heavy flooding. Prototype hepatitis E viruses of genotypes I and II were obtained from such endemic cases. In developed countries, in contrast, hepatitis E was rare and diagnosed only in travelers or imported cases. However, the development of accurate diagnostic tests, mainly PCR detection elucidated that autochthonous hepatitis E in developed countries is far more common than previously thought. Although the main route of transmission is food-borne, other routes including blood-borne have been suggested. Recent developments of gene-based diagnostic assays and molecular epidemiology have disclosed the significance of hepatitis E virus infection in developed countries.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21443914     DOI: 10.1016/j.virusres.2011.03.006

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  Genotype 3 diversity and quantification of hepatitis E virus RNA.

Authors:  Florence Abravanel; Karine Sandres-Saune; Sebastien Lhomme; Martine Dubois; Jean-Michel Mansuy; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Hepatitis E in Singapore: A Case-Series and Viral Phylodynamics Study.

Authors:  Esmeralda Chi-Yuan Teo; Boon-Huan Tan; Michael A Purdy; Pui-San Wong; Pei-Jun Ting; Pik-Eu Jason Chang; Lynette Lin-Ean Oon; Amanda Sue; Chong-Gee Teo; Chee-Kiat Tan
Journal:  Am J Trop Med Hyg       Date:  2017-01-16       Impact factor: 2.345

Review 3.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

4.  Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany.

Authors:  Andi Krumbholz; Sebastian Joel; Paul Dremsek; Anne Neubert; Reimar Johne; Ralf Dürrwald; Mario Walther; Thomas H Müller; Detlef Kühnel; Jeannette Lange; Peter Wutzler; Andreas Sauerbrei; Rainer G Ulrich; Roland Zell
Journal:  Med Microbiol Immunol       Date:  2014-04-18       Impact factor: 3.402

Review 5.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

6.  Hepatitis E virus infection in North Italy: high seroprevalence in swine herds and increased risk for swine workers.

Authors:  L Mughini-Gras; G Angeloni; C Salata; N Vonesch; W D'Amico; G Campagna; A Natale; F Zuliani; L Ceglie; I Monne; M Vascellari; K Capello; G DI Martino; N Inglese; G Palù; P Tomao; L Bonfanti
Journal:  Epidemiol Infect       Date:  2017-11-17       Impact factor: 4.434

7.  Molecular detection of hepatitis E virus in sheep from southern Xinjiang, China.

Authors:  Junyuan Wu; Fusheng Si; Chunyu Jiang; Tao Li; Meilin Jin
Journal:  Virus Genes       Date:  2015-04-02       Impact factor: 2.332

Review 8.  Mechanism of Cross-Species Transmission, Adaptive Evolution and Pathogenesis of Hepatitis E Virus.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Hiroaki Okamoto
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

9.  Hepatitis E virus genotype 3 in wild rats, United States.

Authors:  Justin B Lack; Kylie Volk; Ronald A Van Den Bussche
Journal:  Emerg Infect Dis       Date:  2012-08       Impact factor: 6.883

10.  Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan.

Authors:  Jian-Te Lee; Pei-Lan Shao; Luan-Yin Chang; Ning-Shao Xia; Pei-Jer Chen; Chun-Yi Lu; Li-Min Huang
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.